Leaflet: information for theuser
Sertraline cinfa 150mg film-coated tablets
Sertraline cinfa 200 mg film-coated tablets
Sertraline hydrochloride
Read this leaflet carefully before you start taking thismedicine, because it contains important information for you.
1.What isSertraline cinfa and what is it used for
2.What you need to know before starting to take Sertraline cinfa
3.How to take Sertraline cinfa
4.Possible side effects
5.Storage of Sertraline cinfa
6.Contents of the pack and additional information
Sertralina cinfa contains sertraline as the active ingredient. Sertralinebelongs to a group of medicines calledSelective Serotonin Reuptake Inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders.
Sertralinecan be used to treat:
Depression is a clinical disease with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as one used to.
OCD and anxiety disorders are linked to anxiety, with symptoms such as being constantly preoccupied with repeated ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that may occur after a very emotionally traumatic experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety disorder. It is characterized by feeling intense anxiety or anguish in social situations (for example: speaking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a shameful manner).
Your doctor has considered that this medicine is suitable for treating your condition.
If you are unsure why you have been prescribed sertraline, you should consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take sertraline.
Medicines are not always suitable for everyone. Before starting treatment with sertraline, tell your doctor if you have or have had any of the following circumstances:
Restlessness/Acatisia:
The use of sertraline has been associated with unpleasant restlessness and a need to move, often accompanied by an inability to sit or stand still (acatisia). This happens more often during the first few weeks of treatment. Increasing the dose may be harmful, so if you develop these symptoms, you should contact your doctor.
Withdrawal symptoms:
Side effects related to stopping treatment (withdrawal symptoms) are common, particularly if treatment is stopped abruptly (see section 3. If you stop taking Sertralina cinfa and section 4. Possible side effects). The risk of withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first few days after stopping treatment. In general, these symptoms usually resolve on their own and usually resolve within two weeks. In some patients, they may last longer (2-3 months or more). It is recommended that when stopping treatment with sertraline, the dose is gradually reduced over a period of several weeks or even months, and you should always agree with your doctor on the best way to stop treatment.
Thoughts of suicide and worsening of your depression or anxiety:
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or suicidal thoughts. This may increase at the beginning of treatment with antidepressants, as all these medicines take time to work, which is usually two weeks but can be longer.
You are more likely to experience this:
If you have thoughts of harming yourself or suicidal thoughts at any time, contact your doctor or go to the hospital immediately.
It may be helpful for you to explain to a close family member or friend that you are depressed or have anxiety, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Sexual problems
Some medicines in the group to which Sertralina cinfa belongs (called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Children and adolescents
Normally, sertraline should not be used to treat children and adolescents under 18 years old,except in the case of patients with obsessive-compulsive disorder (OCD). Young patients are at greater risk of side effects such as suicidal thoughts,thoughts of harming themselves or suicidal thoughts(suicidal ideas) and hostility (mainly aggression, confrontational behavior, and irritable reaction) when treated with this class of medicines.However, your doctor may decide to prescribe sertraline to a patient under 18 years old if they consider it to be the best option for the patient. If your doctor has prescribed sertraline and you are under 18 years old and want to discuss this decision, please contact your doctor.
You should inform your doctor if any of the symptoms listed above appear or worsen while you are taking sertraline. At the same time, the long-term safety effects and those related to growth, maturity, and learning (cognitive development) and behavioral development of sertraline in this age group have not yet been demonstrated.
Taking Sertralina cinfa with other medicines
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Some medicines may affect how sertraline works, or sertraline itself may reduce the effectiveness of other medicines you are taking at the same time.
The use of sertraline with the following medicines may cause serious side effects:
Inform your doctor if you are taking the following medicines:
Taking Sertralina cinfa with food, drink, and alcohol
Sertraline tablets can be taken with or without food.
You should avoid drinking alcohol while taking sertraline.
You should not take sertraline with grapefruit juice, as this may increase the levels of sertraline in your body.
Pregnancy, breast-feeding, and fertility
If you are pregnant or breast-feeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
The safety of sertraline in pregnant women has not been fully established. If you are pregnant, sertraline will only be given to you if your doctor considers that the benefits for you outweigh any possible risk to the developing baby.
Make sure your midwife and/or doctor know that you are taking sertraline. If you take sertraline during pregnancy, especially in the last three months of pregnancy, medicines like sertraline may increase the risk of a serious condition in newborn babies called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and appear blue. These symptoms usually start within the first 24 hours after birth. If this happens to your baby, contact your midwife and/or doctor immediately.
Your newborn baby may have other conditions, which usually occur within the first 24 hours after birth. The symptoms include:
• difficulty breathing,
• blue skin or too hot or cold,
• blue lips,
• vomiting or feeding problems,
• excessive tiredness, unable to sleep, or crying a lot,
• stiffness or decreased muscle tone,
• tremors, restlessness, or convulsions,
• increased reflexes,
• irritability,
• low blood sugar.
If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.
If you take sertraline in the final stages of pregnancy, there may be a higher risk of heavy vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking sertraline so they can advise you.
There is some indication that sertraline passes into breast milk. Therefore, sertraline can only be used by women who are breast-feeding if your doctor considers that the benefits outweigh any possible risk to the baby.
In animal studies, some medicines like sertraline have been shown to reduce the quality of sperm. This could theoretically affect fertility, but the impact on human fertility has not yet been determined.
Driving and operating machinery
Medicines like sertraline can affect your ability to drive or operate machinery. Therefore, do not drive or operate heavy machinery until you know how this medicine affects your ability to do these activities.
Sertralina cinfa contains lactose
This medicine contains lactose. If your doctor has told you that you are intolerant to certain sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Depression and Obsessive-Compulsive Disorder:
The usually effective dose for depression and OCD is 50mg per day. The daily dose can be increased by 50mg at intervals of at least one week, and thus overseveral weeks. The maximum recommended dose is 200mg per day.
Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:
For anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, treatment should begin with a dose of 25mg per day, and increased to 50mg per day after one week.
The daily dose can be increased at intervals of 50mg over a period of several weeks. The maximum recommended dose is 200mg per day.
Use in children and adolescents:
Sertralina should only be used to treat children and adolescents aged 6 to 17 years with OCD.
Obsessive-Compulsive Disorder:
Children aged 6 to 12 years:The recommended starting dose is 25mg per day. After one week, your doctor may increase the dose to 50mg per day. The maximum dose is 200mg per day.
Adolescents aged 13 to 17 years:The recommended starting dose is 50mg per day. The maximum dose is 200mg per day.
If you have liver or kidney problems, inform your doctor and follow the instructions they give you..
Administration form:
Sertralina tablets can be taken with or without food.
Take your medication once a day, either in the morning or at night.
Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It will take several weeks for your symptoms to improve. Treatment of depression should continue for 6 months after improvement.
If you take more Sertralina cinfa than you should:
If you accidentally take an excess ofsertralina, contact your doctor or go to the nearest hospital emergency department. Always carry the medication packaging with you, even if it is empty.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
The symptoms of overdose may include drowsiness, nausea, and vomiting, rapid heart rate, tremors, agitation, dizziness, and in rare cases, unconsciousness.
If you forget to take Sertralina cinfa:
Do not take a double dose to compensate for the missed doses. If you forget to take a dose, do not take it when you remember.Take the next dose when it is due.
If you interrupt treatment with Sertralina cinfa:
Do not stop treatment withsertralina unless your doctor tells you to. Your doctor will want to gradually reduce the dose ofsertralina over several weeks before stopping treatment completely. If you stop treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors. If you experience any of these adverse effects, or any other during the interruption of your treatment withsertralina, please inform your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The most common side effect is nausea. Side effects depend on the dose and often disappear or decrease as treatment continues.
Inform your doctor immediately:
If you experience any of the following symptoms after taking this medicine, as these symptoms can be serious.
The following side effects were observed in clinical trials in adults and after marketing.
Very common(may affect more than 1 in 10 patients):
Insomnia, dizziness, drowsiness, headache, diarrhea, feeling unwell, dry mouth, ejaculation problems, and fatigue.
Common(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000patients):
Frequency not known: cannot be estimated from available data:
*Side effects reported after marketing.
Other side effects in children and adolescents
In clinical trials in children and adolescents, side effects were generally similar to those reported in adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Symptoms that may appear when treatment is stopped
If you stop treatment abruptly, you may experience side effects such asdizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors(see section 3. If you stop treatment with Sertralina cinfa).
There has been an increased risk of bone fractures in patients taking this type of medication.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet.You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthis medicationout ofsight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packagingafter CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Askyour pharmacist how to dispose of the packaging and unused medications. By doing so, you will help protect the environment.
Composition of Sertraline cinfa
Each film-coated tablet contains sertraline hydrochloride equivalent to 150mg of sertralina.
Each film-coated tablet contains sertraline hydrochloride equivalent to 200mg of sertralina.
The other components in sertraline 150 mg tablets are: anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, copovidone, lactose monohydrate, stearic acid, magnesium stearate, hypromellose 2910, titanium dioxide, macrogol.
The other components in sertraline 200 mg tablets are: anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, copovidone, lactose monohydrate, stearic acid, magnesium stearate, hypromellose 2910, titanium dioxide, macrogol, yellow iron oxide.
Appearance of the product and contents of the package
Sertraline 150 mg film-coated tablets are oblong and biconvex, white or almost white, 13 x 6 mm.
Sertraline 200 mg film-coated tablets are oblong and biconvex, yellow, 17 x 7 mm.
Sertraline film-coated tablets are available in aluminum/PVC/PVDC blisters containing 15, 30 and 60 tablets.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
Cinfa Laboratories, S.A.
Carretera Olaz-Chipi, 10. Industrial Estate Areta
31620 Huarte (Navarra) – Spain
Manufacturer responsible:
Ferrer Internacional, S.A
Joan Buscallà 1-9
08173 Sant Cugat del Vallès
Spain
This medicine is authorized in the member states of the European Economic Area, with the following names:
Austria | Tresleen |
Belgium, Luxembourg | Serlain |
Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden | Zoloft |
Ireland, Malta, United Kingdom | Lustral |
Spain | Besitran |
Last review date of this leaflet:May 2024
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:
https://cima.aemps.es/cima/dochtml/p/84732/P_84732.html
https://cima.aemps.es/cima/dochtml/p/84733/P_84733.html
QR code to:https://cima.aemps.es/cima/dochtml/p/84732/P_84732.html
QR code to:https://cima.aemps.es/cima/dochtml/p/84733/P_84733.html
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.